Opioid Antagonist class drugs
6 results
Lybalvi (olanzapine and samidorphan l-malate)
(olanzapine and samidorphan L-malate)Alkermes, Inc.
Usage: LYBALVI is indicated for the treatment of schizophrenia in adults and for Bipolar I disorder in adults, including the acute treatment of manic or mixed episodes (as monotherapy or adjunct to lithium/valproate) and for maintenance monotherapy.
Movantik (naloxegol oxalate)
(naloxegol oxalate)RedHill Biopharma Ltd
Usage: MOVANTIK® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage escalation.
Suboxone (buprenorphine hydrochloride, naloxone hydrochloride)
(buprenorphine hydrochloride, naloxone hydrochloride)INDIVIOR INC.
Usage: SUBOXONE sublingual film is indicated for the treatment of opioid dependence and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.
Symproic (naldemedine)
(naldemedine)BioDelivery Sciences International Inc
Usage: SYMPROIC is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or treatment, who do not need frequent opioid dosage increases.
Vivitrol (naltrexone)
(naltrexone)Alkermes, Inc.
Usage: VIVITROL is indicated for the treatment of alcohol dependence in patients who can abstain from alcohol prior to treatment and for preventing relapse to opioid dependence after detoxification. It should be used as part of a comprehensive management program with psychosocial support.
Zubsolv (buprenorphine hydrochloride and naloxone hydrochloride)
(buprenorphine hydrochloride and naloxone hydrochloride)Orexo US, Inc.
Usage: ZUBSOLV is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.